CD-sens: A biological measure of immunological changes stimulated by ASIT

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 5, 2009, Pages 811-814

  Nopp, A ^a,b   Cardell, L O ^c   Johansson, S G O ^a,b   Oman H ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d MIAB   (Sweden)

Author keywords

Basophil; FACS; IgE; Immunotherapy

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G4; POLLEN ANTIGEN;

ARTICLE; BASOPHIL; BLOOD ANALYSIS; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; PRIORITY JOURNAL; PROVOCATION TEST;

ALLERGENS; BASOPHILS; BETULA; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; POLLEN;

EID: 63849135938     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01900.x     Document Type: Article

References (16)

1. Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004 113 : 832 834.
2. Holgate S, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008 8 : 218 230.
3. Cochrane Database Syst Rev. Allergen injection immunotherapy for seasonal allergic rhinitis. 2007 1 : CD001936.
4. Cox L. Accelerated immunotherapy schedules: review of efficacy and safety. Ann Allergy Asthma Immunol 2006 97 : 126 137.
5. Harvey SM, Laurie S, Hilton K, Khan DA. Safety of rush immunotherapy to multiple aeroallergens in an adult population. Ann Allergy Asthma Immunol 2004 92 : 414 419.
6. Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004 113 : 1025 1034.
7. Jutel M, Akdis M, Blaser K, Akdis CA. Mechanisms of allergen specific immunotherapy - T-cell tolerance and more. Allergy 2006 61 : 796 807.
8. Johansson SGO, Nopp A, van Hage M, Olofsson N, Lundahl J, Wehlin L et al. Passive sensitization by blood transfusion. Allergy 2005 60 : 1192 1199.
9. Nopp A, Johansson SGO, Ankerst J, Bylin G, Cardell LO, Grönneberg R et al. Basophil allergen threshold sensitivity. A useful approach to anti-IgE treatment efficacy evaluation. Allergy 2006 61 : 298 302.
10. Nopp A, Johansson SGO, Ankerst J, Palmqvist M, Öman H. CD-sens and clinical changes during withdrawal of Xolair after 6 years of treatment. Allergy 2007 62 : 1175 1181.
11. Marsh DG. Allergens and the genetics of allergy. In : Sela M, editor. The Antigens. London and New York : Academic Press, 1975 : 271 359.
12. Wachholz P, Durham S. Mechanisms of immunotherapy: IgG revisited. Curr Opin Allergy Clin Immunol 2004 4 : 313 318.
13. Röder E, Berger M, de Groot H, van Wijk RG. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review. Pediatr Allergy Immunol 2008 19 : 197 207.
14. Akdis CA, Barlan B, Bahceciler N, Akdis M. Immunological mechanisms of sublingual immunotherapy. Allergy 2006 61 (Suppl. 81 11 14.
15. Stock P, Rolink-Werninghaus C, Wahn U, Hamelmann E. The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis. Biodrugs 2007 21 : 403 410.
16. Francis JN, James LK, Paraskevopulos G, Wong C, Calderon MA, Durham SR et al. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 2008 121 : 1120 1125.